Early neonatal bilirubin, hematocrit, and glucose-6-phosphate dehydrogenase status

Pediatrics

Volumn 134, Issue 4, 2014, Pages e1082-e1088

  Badejoko, Bolaji O ^a   Owa, Joshua A ^a   Oseni, Saheed B A ^a   Badejoko, Olusegun ^a,b   Fatusi, Adesegun O ^b,c   Adejuyigbe, Ebunoluwa A ^a  

^a Department of Paediatrics ^*  (Nigeria)

^b OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^c OBAFEMI AWOLOWO UNIVERSITY TEACHING HOSPITALS COMPLEX   (Nigeria)

Author keywords

Bilirubin haematocrit; Glucose 6 phosphate dehydrogenase; Neonate; Nigeria

Indexed keywords

BILIRUBIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; BIOLOGICAL MARKER;

APGAR SCORE; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; GESTATIONAL AGE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMATOCRIT; HIGH RISK INFANT; HUMAN; HYPERBILIRUBINEMIA; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN JAUNDICE; OBSERVATIONAL STUDY; PATIENT MONITORING; PHOTOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; AGE; BLOOD; FOLLOW UP; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HYPERBILIRUBINEMIA, NEONATAL; NIGERIA; PROCEDURES; TRENDS;

AGE FACTORS; BILIRUBIN; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HEMATOCRIT; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; MALE; NIGERIA; PROSPECTIVE STUDIES;

EID: 84925546568     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-0654     Document Type: Article

References (20)

1. Ogunlesi TA, Dedeke IO, Adekanmbi AF, Fetuga MB, Ogunfowora OB. The incidence and outcome of bilirubin encephalopathy in Nigeria: a bi-centre study. Niger J Med. 2007;16(4):354-359
2. Owa J, Taiwo O, Adebiyi J, Dogunro S. Neonatal Jaundice at Wesley Guild Hospital, Ilesa and Ife State Hospital, Ile-Ife. Niger J Paediatr. 1989;16(1&2):23-30
3. Owa J, Dawodu A, Familusi J. Kernicterus in Nigerian infants. West Afr J Med. 1987;6:11-20
4. Slusher TM, Vreman HJ, McLaren DW, LewisonLJ,BrownAK,StevensonDK.Glucose-6-phosphate dehydrogenase deficiency and carboxyhemoglobin concentrations associated with bilirubin-related morbidity and death in Nigerian infants. J Pediatr. 1995; 126(1):102-108
5. Owa JA. Relationship between exposure to icterogenic agents, glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Nigeria. Acta Paediatr Scand. 1989;78(6):848-852
6. Owa JA, Dawodu AH. Influence of glucose-6-phosphate dehydrogenase status on bilirubin and hematocrit in healthy Nigerian neonates. Niger Med Pract. 1991;22:47-49
7. Engle WA. A recommendation for the definition of "late preterm" (near-term) and the birth weight-gestational age classification system. Semin Perinatol. 2006;30(1):2-7
8. Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R. New Ballard Score, expanded to include extremely premature infants. J Pediatr. 1991;119(3):417-423
9. Beutler E, Mitchell M. Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency. Blood. 1968;32(5):816-818
10. Cheesbrough M. District Laboratory Practice in Tropical Countries. 2nd ed. Cambridge, UK: Cambridge University Press; 2006:362-378
11. Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF. Hyperbilirubinemia in the newborn infant . or =35 weeks' gestation: an update with clarifications. Pediatrics. 2009;124(4):1193-1198
12. Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis. 2009;42(3):267-278
13. Olowe SA, Ransome-Kuti O. The risk of jaundice in glucose-6-phosphate dehydrogenase deficient babies exposed to menthol. Acta Paediatr Scand. 1980;69(3):341-345
14. Kaplan M, Herschel M, Hammerman C, Hoyer JD, Stevenson DK. Hyperbilirubinemia among African American, glucose-6-phosphate dehydrogenase-deficient neonates. Pediatrics. 2004;114(2). Available at: www.pediatrics.org/ cgi/content/full/114/2/e213
15. Kaplan M, Muraca M, Vreman HJ, et al. Neonatal bilirubin production-conjugation imbalance: effect of glucose-6-phosphate dehydrogenase deficiency and borderline prematurity. Arch Dis Child Fetal Neonatal Ed. 2005;90(2):F123-F127
16. Kaplan M, Slusher T, Renbaum P, et al. (TA)n UDP-glucuronosyltransferase 1A1 promoter polymorphism in Nigerian neonates. Pediatr Res. 2008;63(1):109-111
17. Kaplan M, Muraca M, Hammerman C, et al. Bilirubin conjugation, reflected by conjugated bilirubin fractions, in glucose-6-phosphate dehydrogenase-deficient neonates: a determining factor in the pathogenesis of hyperbilirubinemia. Pediatrics. 1998;102 (3). Available at: www.pediatrics.org/cgi/ content/full/102/3/E37
18. Maisels JM. Jaundice. In: MacDonald MG SM, Mullet MD, Seshia MMK, eds. Avery's Neonatology Pathophysiology and Management of the Newborn. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2005:768-846
19. Yoshida A, Beutler E, Motulsky AG. Human glucose-6-phosphate dehydrogenase variants. Bull World Health Organ. 1971;45(2): 243-253
20. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297-316